Select Page
2015, Volume 8, Issue 2, pp 187 – 192
Dumitrescu R * ***
Mehedintu C * **
Briceag I ***
Purcărea VL *
Hudita D *
* “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
** Gynecology Department, “Nicolae Malaxa Hospital”, Bucharest, Romania
*** Gynecology Department, “Dr. I. Cantacuzino Hospital”, Bucharest, Romania
Correspondence to:Ruxandra Dumitrescu, MD, Gynecology Department “Dr. I. Cantacuzino Hospital”, 5-7 Ion Movila Street, Bucharest , Romania Mobile phone: +40 722 703 903, E-mail: [email protected]
Oligo-anovulation, hyperandrogenism and insulin resistance characterizes polycystic ovary syndrome (PCOs). Metformin is the oldest insulin sensitizer used in the management of type 2 diabetes mellitus. In PCOs, metformin decreases the serum lipids, androgen and insulin; induces ovulation and regular menstrual cycle; increases the pregnancy rate.
PMC ID: 4392089
PubMed ID: 25866577
DOI:
Article Publishing Date (print): 2015-Apr-Jun
Available Online:
ISSN Printing: 1844-122X
ISSN Online: 1844-3117
Journal Title: Journal of Medicine and Life
Copyright License: Open Access
This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/